Dendritic cells (DCs) are specialized antigen-presenting cells that play pivotal roles in initiating immune responses. However, DC maturation is usually strongly restricted by the stromal microenvironment, especially in non-lymphoid tissues, such as skin and mucosa. Although suppression of DC maturation by stromal cells has been well documented, the molecular basis of this suppression has not been established. In this study, we examined the role of fibroblasts for DC maturation in vitro. The mouse embryonic fibroblasts (MEFs) strongly suppressed LPS-induced DC maturation. Although suppression of class II MHC and CD40 required DC-MEF contact, soluble factors in the culture supernatant of MEFs were sufficient for the suppression of IL-12 and tumor necrosis factor-a production. Using molecular-size selection and HPLC, we determined that prostaglandin E 2 (PGE 2 ) is a major soluble inhibitory factor secreted by MEFs. This was confirmed by the fact that cyclooxygenase inhibitors inhibited the production of the suppressive factor by MEFs. These results suggest that PGE 2 is a major soluble factor produced by MEFs for the suppression of inflammatory cytokine production from DCs, while a contact mechanism between MEFs and DCs is required for the suppression to induce T cell-stimulating molecules.
Introduction
Dendritic cells (DCs) are specialized antigen-presenting cells (APCs) that play pivotal roles in initiating immune responses (1) . Immature DCs are located in non-lymphoid tissues, such as skin and mucosa, and function as sentinels. After antigen uptake and inflammatory stimulation, immature DCs in peripheral tissues become mature. Mature DCs down-regulate antigen-capturing machinery and up-regulate MHC-peptide complexes, co-stimulatory molecules, selected chemokine receptors and the production of various cytokines. These lead mature DCs to migrate to secondary lymphoid organs, where they activate T cells and direct the differentiation of activated T cells into an effector T cell subtype. The creation of a particular cytokine environment by DCs is critical for the determination of the appropriate type of immune response (2) . DCs have another important role, namely, to induce immunological tolerance. Tolerogenic DCs maintain immune homeostasis by inducing tolerance to selfantigens and have also been shown to actively suppress experimental autoimmune diseases (3) (4) (5) (6) . Tolerogenic DCs have been induced by anti-inflammatory agents, such as IL-10, transforming growth factor (TGF-b), and inducers of cAMP (7) .
Stromal cells are not only structural elements in tissues but also participate in the regulation of inflammation and immune responses (8) . There is accumulating evidence that the stromal microenvironment plays an important role in the regulation of DC functions and in DC priming (9) (10) (11) . Furthermore, several reports have shown that fibroblasts, mainly stromal cells taken from diseased tissues, display a phenotype that is fundamentally different from that of fibroblasts taken from normal tissues at the same anatomical site (12) (13) (14) . In addition, it has been reported that thymic stromal fibroblasts inhibit the production of IL-12 and tumor necrosis factor (TNF)-a from DCs through unknown soluble factors (15) . Mesenchymal stem cells (MSC), which are believed to support the growth and differentiation of hematopoietic stem cells, have also been shown to inhibit DC maturation and migration (16) . As the mechanism of MSC-induced inhibition of DC function, soluble factors, such as IL-6 (17), or prostaglandin E 2 (PGE 2 ) (19) , have been reported. In addition to normal cells, various types of tumor cells also inhibit DC functions and interfere with immune response (20) . Vascular endothelial growth factor, M-CSF, IL-6, IL-10 or gangliosides have been proposed as suppressive factors from tumor cells, and the STAT3 pathway has been shown to be particularly important for the inhibition of DC function (21, 22) . Furthermore, it has also been reported that exosomes secreted from tumor cells inhibit the differentiation of DCs (23) . Therefore, various suppressive mechanisms seem to exist; however, the contribution of these mechanisms to specific situations remains to be elucidated.
In the current study, we investigated the possible involvement of fibroblasts in the regulation of DCs using an in vitro co-culture system. We found that mouse embryonic fibroblasts (MEFs) suppress the maturation of bone marrowderived dendritic cells (BMDCs) by reducing (i) the expression of MHC class II, CD86 and CD40, (ii) the production of IL-12 and TNF-a and (iii) the activity of BMDCs to induce T cell proliferation. A major part of the suppression of cytokine production can be explained by soluble factors from MEFs. We have identified PGE 2 as a major soluble suppressive factor secreted from MEFs. Although PGE 2 can explain the suppression of cytokine production from BMDCs, cell-to-cell contact was still required for full suppression of the maturation of BMDCs. Our data suggest that fibroblasts actively participate in the regulation of DCs by suppressing the maturation of DCs through both PGE 2 and unknown cell-to-cell contact mechanisms.
Methods

Mice and reagents
To delete the Stat3 gene in hemopoietic stem cells, Tie2-Cre mice were crossed with Stat3 fl/fl mice (24, 25) . Age-matched Stat3 fl/fl (Stat3 +/+ ) and Tie2-Cre:Stat3 fl/fl (Stat3 À/À ) mice were used for the preparation of BMDCs. All experiments were approved by the Animal Ethics Committee of Kyushu University. NS-398 was purchased from Sigma (Sigma-Aldrich, St Louis, MO, USA). PGE 2 was purchased from Nacalai Tesque (Kyoto, Japan).
DC and MEF preparation
BMDCs were prepared from a bone marrow suspension obtained from the femurs and tibias of C57BL/6 mice as described elsewhere (26) . Bone marrow cells were cultured in an RPMI 1640 medium supplemented with 10% FCS, L-glutamine, b-mercaptoethanol, antibiotics and 20 ng ml À1 murine granulocyte macrophage colony-stimulating factor (GM-CSF) (PeproTech, Rocky Hill, NJ, USA) or a culture supernatant from J558L cells transfected with the murine Csf2 gene. After 6 days, cells were harvested, counted and then used as BMDCs. Immortalized MEFs were prepared with SV40 large T antigen as described (27) .
Co-culture of BMDCs and MEFs
For live MEFs, 5 3 10 5 MEFs were seeded in 24-well plates. After 12 h, 5 3 10 5 BMDCs were added and then stimulated with 200 ng ml À1 LPS for 12 (flow cytometric analysis) or 24 h (ELISA). The 5 3 10 5 apoptotic MEFs were mixed with BMDCs at 1 h before stimulation. Apoptotic MEFs were prepared by UV-C irradiation.
Flow cytometric analysis
BMDCs and MEFs were stained with APC-conjugated antiCD11c, biotin-conjugated anti-CD45.2, FITC-conjugated anti-CD40 and PE-conjugated anti-I-A or FITC-conjugated anti-CD86 and PE-conjugated anti-CD80. For the co-culture experiments, CD11c + CD45.2 + cells were regarded as DCs.
ELISA
For the assessment of cytokine production, supernatants were collected 24 h after LPS stimulation of BMDCs. 
Western blotting analysis
Western blotting was performed as described elsewhere (28) . In brief, BMDCs (5 3 10 5 ) were treated with LPS at the indicated times and then collected and lysed with an NP40 lysis buffer. Proteins were separated by 10% SDS-PAGE, transferred onto nitrocellulose membranes and incubated with antibodies reactive to phospho-ERK, phospho-IjB, phospho-JNK, phospho-p38, phospho-STAT1, phospho-STAT3 (Cell Signaling Technology, Danvers, MA, USA) or total-STAT3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The optimal antibody concentrations were determined in pilot assays.
Preparation of CD4 + T cells and Mixed Lymphocyte Reaction
Spleen and lymph node cells of BALB/c were incubated with anti-CD4-coated MACS magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany) and positively selected (29) . The purity of CD4 + T cells was >95%, as determined by flow cytometry. BMDCs co-cultured with MEFs for 12 h were prepared by positive selection with anti-CD11c-coated MACS magnetic beads. CD4 + T cells (2 3 10 5 ) from BALB/c mice were co-cultured with each BMDCs treated with or without LPS in an RPMI 1640 medium supplemented with 10% FCS, L-glutamine, b-mercaptoethanol and antibiotics. Cell proliferation was assessed after 72 h of culture by a [ 3 H]thymidine incorporation assay. For a re-stimulation assay, expanded T cells (4 3 10 5 ) were re-stimulated with plate-bound anti-CD3 antibody and then cell proliferation and cytokine production were assessed.
HPLC procedures
The supernatant from MEFs was filtered using YM-3 Centriprep Ultracel (Millipore, Billerica, MA, USA). This supernatant (Mr < 3 K) was dried and diluted with the same volume of acetonitrile containing 0.1% trifluoroacetic acid and applied to a Waters Sep-Pak tC4 cartridge. The cartridge was washed with 40% acetonitrile containing 0.1% trifluoroacetic acid and eluted with 60% acetonitrile containing 0.1% trifluoroacetic acid. The eluate was diluted with a 0.5 volume of deionized water containing 0.1% trifluoroacetic acid and subjected to reverse-phase high-pressure liquid chromatography using a COSMOSIL 5C4 column (Nacalai Tesque) at a flow rate of 0.5 ml min À1 with a 40-80% acetonitrile linear gradient containing 0.1% trifluoroacetic acid. The suppressive activity was detected by the production of TNF-a with ELISA.
Statistics
Statistical analysis was carried out using the two-sided, unpaired Student's t-test or the two-sided Welch test. Differences were judged to be statistically significant when the P value was <0.05.
Results
Live MEFs suppress the maturation of BMDCs by LPS
DC maturation in vivo is regulated by the stromal microenvironment, including stromal cells and the extracellular matrix. To examine whether fibroblasts affect DC maturation, we cocultured BMDCs with primary MEFs and then stimulated them with LPS. LPS-induced DC maturation associated with the enhanced expression of CD40, CD86 and MHC class II molecules ( Fig. 1A and data not shown). We found that the co-culture with live MEFs suppressed LPS-induced DC maturation. This suppression was observed when the ratio of MEFs to DCs exceeded 1:30 ( Fig. 1B ) and was checked in more than three different clones of MEFs and immortalized MEFs. It has been reported that the co-culture of DCs with apoptotic cells suppresses the maturation of DCs (30, 31) . Surprisingly, the suppression of DC maturation by live MEFs was more effective than the equal number of apoptotic MEFs. This suppression was not observed when another metabolically active cell population, such as HEK293T or fibroblast-like cell line ST2, was used instead of MEFs (data not shown). These results indicate that the suppression of DC maturation by MEFs is not caused by non-specific effects, such as exhaustion of nutrient in medium. Furthermore, MEFs suppressed DC maturation by other TLR ligands [peptideglycan, CpG or poly (I:C)], TNF-a or IFN-c, as well as LPS (data not shown). Fully matured DCs produce various cytokines, such as IL-12, TNF-a, IL-10 and IL-6. The co-culture with live MEFs also suppressed the secretion of the IL-12 p40 subunit and TNF-a from LPS-stimulated BMDCs, while the levels of IL-6 and IL-10 remained unchanged (Fig. 1C) .
We then examined whether the co-culture with MEFs altered the ability of BMDCs to function as APCs.
Allogeneic CD4
+ T cells were incubated with BMDCs or MEF-conditioned BMDCs for 3 days. As shown in Fig. 1(D) , MEF-conditioned BMDCs failed to induce T cell proliferation. Furthermore, T cells primed with MEF-conditioned BMDCs responded weakly to a secondary stimulation with anti-CD3 antibody (Fig. 1E ), suggesting that these T cells were in the state of anergy. These results suggest that live fibroblasts suppress the DC maturation and modulate the DC functions.
MEFs do not affect TLR4 signaling
To investigate the molecular basis for the MEF-mediated suppression of DC maturation, we examined the TLR signaling pathways. LPS activates the mitogen-activated protein kinase (MAPK), nuclear factor jB (NF-jB) and interferon regulatory factor (IRF) pathways through TLR4 (32) . The NF-jB and the p38 pathways are important for the production of TNF-a (33), while the ERK pathway negatively regulates IL-12 production (34). As shown in Fig. 2A , ERK, IjB, p38, JNK and STAT1 in DCs were phosphorylated by the stimulation with LPS in each time point. The levels of phosphorylation of these molecules by LPS were not significantly altered in DCs co-cultured with MEFs ( Fig.  2A) . These results suggest that the suppressive effects by MEFs are not due to the modulation of TLR4 signals, at least upstream of these molecules. Interestingly, the coculture with MEFs gave constitutive ERK activation to DCs ( Fig. 2A , time 0 of MEFs). Although the inhibitor of the ERK pathway, PD98059 or U0126, efficiently suppressed the phosphorylation of ERK by MEFs (Fig. 2B and data not shown), they could not restore the production of IL-12 and TNF-a or the enhanced expression of the surface antigens ( Fig. 2C and D and data not shown). These results indicate that the constitutive ERK activation by MEFs is not involved in the suppression of DC maturation.
Suppression of BMDC maturation by MEFs is independent of STAT3
Next, we tried to identify the factors that suppress LPSinduced maturation of DCs. It has been established that STAT3 negatively regulates inflammatory responses, and the cytokines activating STAT3, such as IL-10, IL-27 and IL-6, plays an important role in MSC-and tumor cell-induced suppression of DC function (17, 18, 22, (35) (36) (37) . As shown in Fig. 1 , MEFs did not suppress IL-6 and IL-10 expression in DCs. Thus, we investigated the role of STAT3 in the MEFinduced suppression of DC maturation. Because STAT3-deficient mice die during early embryogenesis, we used Tie2Cre-Stat3 flox/flox mice, in which the Stat3 gene has been deleted in all hemopoietic lineages. Although STAT3 is indispensable in Flt3L-regulated DC development, STAT3-deficient bone marrow cells can differentiate normally into CD11c + DC in response to GM-CSF and subsequently mature in response to LPS (38) . The STAT3 level was efficiently decreased in BMDCs from these mice (Fig. 3A) . As expected, the suppression of maturation by IL-10 was not observed in BMDCs from Tie2Cre:Stat3 fl/fl mice (Fig. 3B) . However, co-cultured MEFs still suppressed the secretion of IL-12 p70 and TNF-a from STAT3-deficient BMDCs, whereas the secretion of IL-6 was not altered (Fig. 3B) . Surface molecules, such as CD40 and MHC class II, were also suppressed by MEFs in STAT3-deficient BMDCs (data not shown). These results indicate that the MEF-mediated suppression of DCs is independent of the STAT3 pathway.
Suppression of BMDC maturation by MEFs is partly due to soluble factors
To determine whether the immunosuppressive effects of MEFs were due to soluble factors secreted from MEFs, we examined the suppressive activity of the culture supernatant of MEFs [mouse embryonic fibroblast-conditioned medium (MCM)]. MCM, as well as co-cultured MEFs, showed suppressive effects on the secretion of IL-12 p70 and TNF-a, similar to co-cultured MEFs (Fig. 4A) . This suppression by MCM did not require the stimulation to MEFs with LPS, and its suppressive activity was not altered by the presence of LPS (data not shown). On the contrary, the degree of suppression of the surface markers, CD40 and MHC class II, by MCM was weaker than that by the co-culture with MEFs (Fig. 4B) . Interestingly, the expression of CD80 was enhanced by the co-culture with MEFs, and this was not observed by MCM treatment. These data indicate that soluble factors from MEFs are sufficient to suppress cytokine secretion, whereas the complete suppression or modulation of surface molecules requires cell-to-cell contact.
Prostaglandin E 2 is the major suppressive soluble factor secreted by MEFs
To identify the soluble factors responsible for the suppression of cytokine secretion, MCM was applied to a series of ultrafiltration columns, and fractions were tested for inhibition of cytokine production from LPS-stimulated BMDCs. We determined that the relative molecular weight of the suppressive factors was <3000 Da (data not shown). Furthermore, as the suppressive activity of this filtrate was not diminished by the treatment with proteases and boiling, the soluble factors in MCM did not seem to be oligopeptides or proteins (data not shown). Next, <3 kD ultrafiltrated materials were resolved further by HPLC with a reverse-phase (C4) column (Fig. 5A ). As shown in Fig. 5(C) , fractions 6 and 8 showed suppressive activity. Although we could not determine the molecular structure of this fraction from the HPLC profile, we suspected that it might contain prostanoids. PGE 2 has been shown to suppress IL-12 production by monocytes and DCs (39) . Therefore, we analyzed the HPLC profile of chemically synthetic PGE 2 to HPLC under the same conditions as for MCM. Synthetic pure PGE 2 was eluted near fractions #6-8 (Fig. 5B) .
To analyze this more precisely, we examined the MCM materials with a narrower gradient setting. Under these conditions, suppressive activity was observed in two peaks (#28-30 and #32). The ELISA assay and standard PGE 2 elution profile confirmed that fractions #28-30 but not fraction #32 contained PGE 2 (Fig. 5D) . Fraction #32 may have contained other suppressive factors; however, judging from the activity of this fraction, the contribution of this material was minor. The calculated concentration of PGE 2 in MCM was ;10 nM, which was sufficient to suppress the cytokine secretion from BMDCs (Fig. 5E) .
To confirm that PGE 2 is the major suppressive factor in MCM, we prepared MCM from MEFs treated with cyclooxygenase (COX) inhibitors. The suppressive activity of total MCM was nearly canceled by treating MEFs with COX inhibitors, NS398 and indomethacin ( Fig. 5F and data not shown). These data indicate that a major soluble suppressive factor secreted from MEFs is PGE 2 .
Effect of MCM and PGE 2 on DC maturation and T cell activation
Next, we examined the effect of MCM and PGE 2 on the ability of BMDCs to induce T cell proliferation. High concentrations (>100 nM) of PGE 2 suppressed anti-TCR antibodymediated T cell proliferation; however, 10 nM PGE 2 did not affect T cell proliferation (data not shown). Unlike the co-culture system, CD4
+ T cell proliferation induced by MCM-treated or PGE 2 -treated BMDCs was similar to that induced by control BMDCs (Fig. 6) . Thus, the suppression of T cell proliferation by MEFs is mostly dependent on cell-cell contact but not on soluble factors. These data suggest that PGE 2 is the major factor in MCM only for the suppression of cytokine production from DCs, while the full suppression of DC maturation requires cell-cell contact.
Discussion
DCs play important roles in the control of the adaptive immune response. Immature DCs are located in non-lymphoid tissues, such as skin and mucosa, and they always interact with stromal microenvironment in vivo. However, maturation of DCs has been studied using isolated DCs in in vitro systems. In the present paper, we examined the role of fibroblasts on DC maturation using a co-culture system. Under our experimental conditions, co-cultured MEFs suppressed the expression of surface molecules of LPS-stimulated BMDCs, which are involved in T cell activation, and the production of pro-inflammatory cytokines, IL-12 and TNF-a, but not IL-6 and IL-10, without affecting TLR4 signaling (Figs 1   and 2) . Our data clearly demonstrate that microenvironments including fibroblasts are important as immunoregulatory cells. In the intestine, mucosal DCs must avoid exaggerated inflammatory response to commensal bacteria, which express TLR ligands. Rimoldi et al. (40) have reported that intestinal epithelial cells induce DCs to become noninflammatory DCs in the lamina propria, which release IL-10 and IL-6 but not IL-12. It has also been reported that stromal cells in the murine small intestine spontaneously and continuously express COX-2 and produce abundant PGE 2 , which controls the immune response in the small intestine (41, 42) . In addition, two groups have reported that splenic stromal cells induce mature DCs to differentiate into a unique type of DCs with regulatory functions (10, 11) . Contrary to these observations, Saalbach et al. (9) reported that dermal fibroblasts induce the maturation of DCs in humans. This discrepancy might be due to differences between mice and humans or between dermal and embryonic fibroblasts.
Experiments using MCM have shown that soluble factors were sufficient for the suppression of the production of IL-12 and TNF-a (Fig. 4) . We identified PGE 2 in MCM as a major inhibitor of pro-inflammatory cytokine production from DCs. PGE 2 has a large number of biological actions. It has been reported that PGE 2 inhibits DC maturation (43) and cytokine secretion from macrophages and DCs (44, 45) . In fact, under our experimental conditions, MCM contained ;10 nM PGE 2 , which is sufficient for the suppression of the production of IL-12 and TNF-a. Although the co-culture of BMDCs with MEFs did not affect the production of IL-6 from BMDCs (Fig. 1C) , MCM or PGE 2 partially suppressed the production of IL-6 (Fig. 5) . This discrepancy may be due to the production of IL-6 from MEFs by LPS. On the contrary, 10 nM PGE 2 did not significantly affect the expression of class II MHC and co-stimulators in DCs, thereby not affecting the DC function to activate T cells. Thus, cell-cell contact mechanisms must be important for the suppression of TCRmediated T cell proliferation. Although PGE 2 is considered to be a major inhibitor of pro-inflammatory cytokine production from DCs in MCM, we could not exclude that the other COX metabolites are also involved in the suppression by MCM. It has also been reported that the other COX metabolites, such as thromboxane A 2 (TXA 2 ), prostaglandin I 2 (PGI 2 ), prostaglandin D 2 (PGD 2 ) and 15-Deoxy-D 12,14 -prostaglandin J 2 (15d-PGJ 2 ), suppress DC functions (46) (47) (48) (49) (50) . The retention time of thromboxane B 2 and 6-keto prostaglandin F 1 a, which is a stable hydrolysis product of TXA 2 and PGI 2 , respectively, is usually shorter than that of PGE 2 in HPLC (51). Since PGD 2 and 15d-PGJ 2 have been shown to be eluted after PGE 2 (51, 52), PGD 2 and 15d-PGJ 2 are candidates for the suppressive factors in fraction #32. However, we could not identify the molecule in this fraction because of a low amount of material in this fraction.
Molecular mechanisms of PGE 2 -mediated suppression of the production of inflammatory cytokines remained to be elucidated. PGE 2 has known to elevate intracellular cAMP, which leads to the activation of protein kinase A and phosphorylation of the cAMP response element-binding protein (CREB) (53) . Activated CREB may suppress the production of inflammatory cytokines by competing for a limited amount of CREB-binding protein with NF-jB, which is a critical transcription factor for the production of inflammatory cytokines (54, 55) . PGE 2 is also known to enhance IL-10 production, which plays a major role in suppressing inflammatory responses through the STAT3 pathway. However, as soluble factors secreted MEFs also suppressed STAT3-deficient BMDCs (data not shown), the suppression mechanism of PGE 2 is independent of IL-10/STAT3. We are currently investigating how PGE 2 suppresses pro-inflammatory cytokine production.
On the other hand, PGE 2 is also known to play pro-inflammatory roles. Recently, Sheibanie et al. (56, 57) reported that PGE 2 -treated DCs support T h 17 cells by producing IL-23 and contribute to experimental inflammatory bowel disease (56, 57) . We also observed that PGE 2 induce DCs to enhance the expression of p19, a subunit of IL-23, which expands pro-inflammatory T h 17 cells (data not shown). Consistent with this, several others have shown that COX inhibitors ameliorate experimental allergic encephalomyelitis, which is considered to be a model of autoimmune disease, in which T h 17 plays an important role (58, 59) . These diverse effects of PGE 2 may be explained by four different types of receptors, EP1, EP2, EP3 and EP4 (53) . In our experimental conditions, the Th-skewing effect of PGE 2 secreted from MEFs may have been masked by suppression through contact mechanisms of MEFs in a steady state.
The surface molecules of MEFs involved in the suppression of DC maturation and the mechanisms of this suppression are still largely unknown. Apoptotic cells are also known to suppress IL-12 and TNF-a production from DCs as well as maturation of DCs. This suppression has been thought to occur through soluble factors, such as IL-10, TGF-b and PGE 2 , and through cell-cell contact mechanisms including recognition of phosphatidylserine (30, 31, 60, 61) . Kim et al. (62) reported that apoptotic cells suppress the IL-12 production from macrophage through GC-binding protein, a novel zinc finger nuclear factor. However, the suppression by MEFs, which we observed, is not due to apoptotic cells because MEFs in the co-culture condition were viable (data not shown). Therefore, suppression mechanism by cell-cell contact still remained to be determined. Although we suspected that the STAT3 pathway is involved in the suppression by live MEFs, MEFs also suppressed the LPS-induced maturation of STAT3-deficient DCs (Fig. 3) . In addition, the inhibitor of MAPK or phosphoinositide 3-kinase pathway could not restore the DC maturation by LPS (data not shown). Recently, it has been reported that a V b 8 integrin deficiency in DCs causes autoimmunity in mice because a V b 8 integrin induces TGF-b activation (63). Fibroblasts usually express large amounts of TGF-b. However, TGF-bdeficient MEFs did not inhibit the suppression of DC maturation, and treatment of DCs with TGF-b did not suppress the expression of surface markers under our experimental conditions (data not shown). Thus, TGF-b is unlikely to be involved in the suppression of DC maturation by MEFs. Interestingly, co-cultured MEFs increase the expression of CD80 to some extent despite the down-regulation of another co-stimulatory molecule, CD86 (Fig. 4B) . Because CD80 markedly favors CTLA-4, which induces powerful inhibitory signals in T cells (64, 65) , CD80 up-regulation might be a mechanism for the silencing of T cell activation. The molecular basis for the up-regulation of CD80 remains to be investigated.
The innate immune system is the first line of host defense against pathogens. DCs are activated by pathogen-associated molecular patterns through pattern-recognition receptors, such as TLRs (32) . Cell components from stressed or dead cells, which act as danger signals, also activate DCs and then alert the immune system (66) . HMGB1, uric acid and heat-shock proteins have so far been identified as danger signals from damaged cells (67) (68) (69) . In addition to these mechanisms, our data suggest a new mechanism in which a microenvironment including fibroblasts actively suppresses the maturation of DCs transiently and the collapse of the microenvironment, such as that caused by tissue damage or cellular stress caused by infection, leads the release of DCs from the suppression by fibroblasts and functions as an inducer of adaptive immune responses. PGE 2 might modulate the responses of Th cells by altering the cytokine production from DCs when DCs are liberated from MEFs.
In conclusion, we have shown that fibroblasts suppress DC maturation through PGE 2 and a cell-cell contact mechanism. Further study of the molecular mechanisms of this suppression by cell-cell contact is required and such study will yield greater understanding of and possible treatments for various autoimmune diseases.
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